Publications by authors named "Samuel Vic"

Claim this Profile
H
Hypereosinophilia after CAR T-cell therapy.
Bérenger Poirier, Roch Houot, Samuel Vic, Mickael Roussel, Catherine Henry

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study).
Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population.
Samuel Vic, Jean Lemoine, Philippe Armand, François Lemonnier, Roch Houot

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-specific outcomes after chimeric antigen receptor T-cell therapy.
Jean Lemoine, Samuel Vic, Roch Houot

Eur J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia.
Marie-Laure Boulland, Samuel Vic, Florian Thonier, Michel Ganard, Thierry Lamy

Leuk Lymphoma· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis